Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cymabay Therapeutics (CBAY)

14.98 0.11 (0.74%)

02-16 16:00

Open:

14.85

Pre. Close:

14.87

High:

15.25

Low:

14.53

Volume:

1,400,549

Market Cap:

831M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.269 - 15.325

15.325 - 15.371

Low:

14.391 - 14.46

14.46 - 14.516

Close:

14.874 - 14.983

14.983 - 15.071

Technical analysis  (as of: 2018-02-16 4:24:23 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 17.81     One year: 20.80

Support:

Support1: 11.71    Support2: 9.52

Resistance:

Resistance1: 15.25    Resistance2: 17.81

Pivot:

12.53

Moving Averages:

MA(5): 13.81     MA(20): 12.21

MA(100): 9.41     MA(250): 6.83

MACD:

MACD(12,26): 1.07     Signal(12,26,9): 0.83

%K %D:

%K(14,3): 90.15     %D(3): 85.68

RSI:

RSI(14): 77.99

52-Week:

High: 15.25  Low: 2.77  Change(%): 375.6

Average Vol(K):

3-Month: 83251  10-Days 161739

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CBAY has closed above the upper band by 5.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 161.8% wider than normal. The large width of the bands suggest high volatility as compared to CBAY's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Mon, 29 Jan 2018 21:45:00 GMT
CymaBay Therapeutics (CBAY) Commences Common Stock Offering

Mon, 19 Feb 2018 03:22:30 GMT
CymaBay Therapeutics Inc (NASDAQ:CBAY) Director Sells $1437831.20 in Stock

Wed, 14 Feb 2018 12:45:00 GMT
These stock's might change the kismet of Investors: Cymabay Therapeutics, Inc ...

Thu, 15 Feb 2018 15:11:15 GMT
Is It Time to go for ProPetro Holding Corp. (PUMP), Cymabay Therapeutics, Inc ...

Fri, 16 Feb 2018 12:00:00 GMT
Are These Stocks A Sure Bet? – EQT Corporation (EQT), Cymabay Therapeutics ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

43.86

Shares Float (M)

43.48

% Held by Insiders

% Held by Institutions

67.80

Shares Short (K)

2112

Shares Short Prior Month (K)

2720

Stock Financials

EPS

-1.020

EPS Est. Current Year

-0.820

EPS Est. Next Year

-0.740

EPS Est. Next Quarter

-0.160

Forward EPS

-0.880

Book Value (p.s.)

6.080

PEG Ratio

Profit Margin

Operating Margin

-439.31

Return on Assets (ttm)

-45.3

Return on Equity (ttm)

-60.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.644

Qtrly Earnings Growth

Operating Cash Flow (M)

-18.96

Levered Free Cash Flow (M)

-3.04

atoplab.com

Valuation

P/E

-14.69

P/E Growth Ratio

0.01

P/BV

2.46

P/S

5191505920.00

P/CF

-34.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.